Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 12, 2012, Pages 2201-2209

  Barrasa, Juan I ^a   Santiago Gómez, Angélica ^a   Olmo, Nieves ^a   Lizarbe, María Antonia ^a   Turnay, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

ABT 263; Apoptosis; Bcl 2; Bile acid; Butyrate resistance; Human colon adenocarcinoma

Indexed keywords

BILE ACID; BUTYRIC ACID; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL VIABILITY; COLON ADENOCARCINOMA; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; UPREGULATION;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BILE ACIDS AND SALTS; BLOTTING, WESTERN; BUTYRATES; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GASTROINTESTINAL AGENTS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 84867353442     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.08.008     Document Type: Article

References (40)

1. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133:2485S-2493S.
2. Vanhoutvin S.A., Troost F.J., Hamer H.M., Lindsey P.J., Koek G.H., Jonkers D.M., Kodde A., Venema K., Brummer R.J. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One 2009, 4:e6759.
3. Yeung T.M., Chia L.A., Kosinski C.M., Kuo C.J. Regulation of self-renewal and differentiation by the intestinal stem cell niche. Cell. Mol. Life Sci. 2011, 68:2513-2523.
4. Scheppach W., Bartram H.P., Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur. J. Cancer 1995, 31A:1077-1080.
5. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27:104-119.
6. Serpa J., Caiado F., Carvalho T., Torre C., Goncalves L.G., Casalou C., Lamosa P., Rodrigues M., Zhu Z., Lam E.W., Dias S. Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells. J. Biol. Chem. 2010, 285:39211-39223.
7. Powell A.A., Akare S., Qi W., Herzer P., Jean-Louis S., Feldman R.A., Martinez J.D. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity. BMC Cancer 2006, 6:219.
8. Bernstein C., Holubec H., Bhattacharyya A.K., Nguyen H., Payne C.M., Zaitlin B., Bernstein H. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 2011, 85:863-871.
9. Rosignoli P., Fabiani R., De Bartolomeo A., Fuccelli R., Pelli M.A., Morozzi G. Genotoxic effect of bile acids on human normal and tumour colon cells and protection by dietary antioxidants and butyrate. Eur. J. Nutr. 2008, 47:301-309.
10. Bernstein C., Bernstein H., Garewal H., Dinning P., Jabi R., Sampliner R.E., McCuskey M.K., Panda M., Roe D.J., L'Heureux L., Payne C. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res. 1999, 59:2353-2357.
11. Bernstein H., Bernstein C., Payne C.M., Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol. 2009, 15:3329-3340.
12. Barrasa J.I., Olmo N., Pérez-Ramos P., Santiago-Gómez A., Lecona E., Turnay J., Lizarbe M.A. Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells. Apoptosis 2011, 16:1054-1067.
13. Turnay J., Olmo N., Gavilanes J.G., Benítez J., Lizarbe M.A. Establishment and characterization of a new human colon adenocarcinoma cell line: BCS-TC2. Cytotechnology 1990, 3:75-88.
14. Navarro J.M., Olmo N., Turnay J., López-Conejo M.T., Lizarbe M.A. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity. Eur. J. Clin. Invest. 1997, 27:620-628.
15. Olmo N., Turnay J., Pérez-Ramos P., Lecona E., Barrasa J.I., López de Silanes I., Lizarbe M.A. In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells. Toxicol. In Vitro 2007, 21:262-270.
16. López de Silanes I., Olmo N., Turnay J., González de Buitrago G., Pérez-Ramos P., Guzmán-Aránguez A., García-Díez M., Lecona E., Gorospe M., Lizarbe M.A. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells. Cancer Res. 2004, 64:4593-4600.
17. Olmo N., Turnay J., Lecona E., García-Díez M., Llorente B., Santiago-Gómez A., Lizarbe M.A. Acquisition of resistance to butyrate induces resistance to luminal components and other types of stress in human colon adenocarcinoma cells. Toxicol. In Vitro 2007, 21:254-261.
18. Pérez-Ramos P., Olmo N., Turnay J., Lecona E., de Buitrago G.G., Portolés M.T., Lizarbe M.A. Effect of bile acids on butyrate-sensitive and -resistant human colon adenocarcinoma cells. Nutr. Cancer 2005, 53:208-219.
19. Olmo N., Turnay J., González de Buitrago G., López de Silanes I., Gavilanes J.G., Lizarbe M.A. Cytotoxic mechanism of the ribotoxin alpha-sarcin. Induction of cell death via apoptosis. Eur. J. Biochem. 2001, 268:2113-2123.
20. Guzmán-Aránguez A., Olmo N., Turnay J., Lecona E., Pérez-Ramos P., López de Silanes I., Lizarbe M.A. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell. Biochem. 2005, 94:178-193.
21. Weston C.R., Balmanno K., Chalmers C., Hadfield K., Molton S.A., Ley R., Wagner E.F., Cook S.J. Activation of ERK1/2 by deltaRaf-1:ER represses Bim expression independently of the JNK or PI3K pathways. Oncogene 2003, 22:1281-1293.
22. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
23. Fung K.Y., Brierley G.V., Henderson S., Hoffmann P., McColl S.R., Lockett T., Head R., Cosgrove L. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. J. Proteome Res. 2011, 10:1860-1869.
24. Fung K.Y., Lewanowitsch T., Henderson S.T., Priebe I., Hoffmann P., McColl S.R., Lockett T., Head R., Cosgrove L.J. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells. J. Proteome Res. 2009, 8:1220-1227.
25. Crowley-Weber C.L., Payne C.M., Gleason-Guzman M., Watts G.S., Futscher B., Waltmire C.N., Crowley C., Dvorakova K., Bernstein C., Craven M., Garewal H., Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002, 23:2063-2080.
26. Qiao D., Gaitonde S.V., Qi W., Martinez J.D. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis 2001, 22:957-964.
27. Sayan B.S., Sayan A.E., Knight R.A., Melino G., Cohen G.M. p53 is cleaved by caspases generating fragments localizing to mitochondria. J. Biol. Chem. 2006, 281:13566-13573.
28. Wakeyama H., Akiyama T., Kadono Y., Nakamura M., Oshima Y., Nakamura K., Tanaka S. Posttranslational regulation of Bim by caspase-3. Ann. N. Y. Acad. Sci. 2007, 1116:271-280.
29. Tse C., Shoemaker A.R., Adickes J., Anderson M.G., Chen J., Jin S., Johnson E.F., Marsh K.C., Mitten M.J., Nimmer P., Roberts L., Tahir S.K., Xiao Y., Yang X., Zhang H., Fesik S., Rosenberg S.H., Elmore S.W. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 2008, 68:3421-3428.
30. LaRue J.M., Stratagoules E.D., Martinez J.D. Deoxycholic acid-induced apoptosis is switched to necrosis by bcl-2 and calphostin C. Cancer Lett. 2000, 152:107-113.
31. Akare S., Martinez J.D. Bile acid induces hydrophobicity-dependent membrane alterations. Biochim. Biophys. Acta 2005, 1735:59-67.
32. Cheng K., Raufman J.P. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem. Pharmacol. 2005, 70:1035-1047.
33. Araki Y., Katoh T., Ogawa A., Bamba S., Andoh A., Koyama S., Fujiyama Y., Bamba T. Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic. Biol. Med. 2005, 39:769-780.
34. Qiao D., Stratagouleas E.D., Martinez J.D. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 2001, 22:35-41.
35. Qiao L., Han S.I., Fang Y., Park J.S., Gupta S., Gilfor D., Amorino G., Valerie K., Sealy L., Engelhardt J.F., Grant S., Hylemon P.B., Dent P. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol. Cell. Biol. 2003, 23:3052-3066.
36. Redlak M.J., Miller T.A. Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis. Dig. Dis. Sci. 2011, 56:323-329.
37. Luo H., Yang Y., Huang F., Li F., Jiang Q., Shi K., Xu C. Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of beta-catenin survival axis. Cancer Lett. 2012, 315:78-85.
38. Kim K.S., Choi H.W., Yoon H.E., Kim I.Y. Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation. J. Biol. Chem. 2010, 285:40294-40302.
39. Park K.R., Nam D., Yun H.M., Lee S.G., Jang H.J., Sethi G., Cho S.K., Ahn K.S. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPk activation. Cancer Lett. 2011, 312:178-188.
40. Ma X., Ezzeldin H.H., Diasio R.B. Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 2009, 69:1911-1934.